Milestone Group PLC Milestone Group Plc : Issue Of Equity

 
TIDMMSG 
 
   MILESTONE GROUP PLC 
 
   ("Milestone" or the "Company") 
 
   Issue of Equity 
 
   Milestone, the AIM quoted (AIM: MSG) provider of digital media and 
technology solutions, announces that it has agreed to issue 18,010,000 
new ordinary shares of 0.1p per share in the Company, subject to 
Admission to AIM, raising GBP180,100 in cash at a price of 1 pence per 
share. The proceeds will be used for general working capital purposes. 
 
   The 18,010,000 new ordinary shares will rank pari passu with the 
existing ordinary shares of Milestone. 
 
   Application has been made for the 18,010,000 ordinary shares to be 
admitted to trading on AIM, which is expected to occur on or around 25 
February 2016. 
 
   Following the issue, Milestone will have in issue 625,163,582 ordinary 
shares with voting rights. 
 
   The above figure may be used by shareholders as the denominator for the 
calculations by which they will determine if they are required to notify 
their interest in, or a change to their interest in, the Company under 
the Disclosure and Transparency Rules. 
 
   For further information: 
 
 
 
 
 
  Milestone Group PLC                              Tel: 020 7929 7826 
  Deborah White, Chief Executive 
 
Cairn Financial Advisers LLP, Nominated Adviser 
 Liam Murray / Avi Robinson                        Tel: 020 7148 7900 
 
Hybridan LLP, Broker 
 Claire Louise Noyce                               Tel: 020 3764 2341 
 
 
 
   This announcement is distributed by NASDAQ OMX Corporate Solutions on 
behalf of NASDAQ OMX Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Milestone Group PLC via Globenewswire 
 
   HUG#1987505 
 
 
  http://www.milestonegroup.co.uk/

(END) Dow Jones Newswires

February 19, 2016 02:01 ET (07:01 GMT)

Milestone Group (LSE:MSG)
Historical Stock Chart
From Jan 2025 to Feb 2025